Syon Capital’s ADMA Biologics ADMA Stock Holding History

Syon Capital’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,780	Closed	-$215K	–	811
2025 Q2	$215K	Sell	11,780 -1,174	-9%	-$23.9K	0.01%	673
2025 Q1	$257K	Buy	+12,954	New	+$224K	0.02%	471

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Syon Capital's ADMA Position: Q3 2025 in Review

Syon Capital sold out of ADMA Biologics (ADMA) in Q3 2025, closing a stake of 11,780 shares — an estimated $215K sold.

Syon Capital first reported a position in ADMA in Q1 2025 and held it in 2 quarters. The position peaked at $257K in Q1 2025. 365 funds tracked by Wall St. Rank hold ADMA as of Q3 2025.

Syon Capital reported no remaining ADMA Biologics position as of Q3 2025 after selling out during the quarter.
Syon Capital sold 11,780 ADMA Biologics shares in Q3 2025, an estimated $215K.
Syon Capital first reported a position in ADMA Biologics in Q1 2025 and held it in 2 quarters.
Syon Capital's ADMA Biologics position peaked at $257K in Q1 2025.
365 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2025.

Based on Syon Capital's 13F filing for Q3 2025, filed 7 Nov 2025.